| NCT Number | NCT06923137 |
| Lead Sponsor | Pfizer |
| Conditions | COVID-19 SARS-CoV-2 Infection, COVID-19, COVID-19 Infection, Coronavirus Disease 2019 (COVID-19), COVID-19 (Coronavirus Disease 2019), COVID-19 Vaccination, COVID-19 Vaccines, SARS-CoV-2 Infection, COVID19 +1 more |
| Enrollment | 1 participants |
| Start Date | 2025-04-16 |
| Primary Completion | 2030-10-31 (estimated) |
| Study Completion | 2030-10-31 (estimated) |
| Updated on ClinicalTrials.gov | 2025-11-19 |